David Gerring
Corporate Officer/Principal en ARECOR THERAPEUTICS PLC .
Fortuna: 264 284 $ al 30/04/2024
Cargos activos de David Gerring
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ARECOR THERAPEUTICS PLC | Corporate Officer/Principal | - | - |
Arecor Ltd.
 Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - | - |
Historial de carrera de David Gerring
Estadísticas
Internacional
| Reino Unido | 3 |
Operativa
| Corporate Officer/Principal | 2 |
Sectorial
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ARECOR THERAPEUTICS PLC | Health Technology |
| Empresas privadas | 1 |
|---|---|
Arecor Ltd.
Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- David Gerring
- Experiencia
